Article Publish Status: FREE
Abstract Title:

Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice.

Abstract Source:

Cancers (Basel). 2021 Feb 25 ;13(5). Epub 2021 Feb 25. PMID: 33668827

Abstract Author(s):

Youngmin Yoon, Gihyeon Kim, Bu-Nam Jeon, Sungsoon Fang, Hansoo Park

Article Affiliation:

Youngmin Yoon


Colorectal cancer (CRC) is among the leading causes of cancer-related death in the world. The development of CRC is associated with smoking, diet, and microbial exposure. Previous studies have shown that dysbiosis of the gut microbiome affects cancer development, because it leads to inflammation and genotoxicity. Supplementation with specific microbiota induces anti-tumor effects by enhancing of anti-tumor immunity. Here, we observed that supplementation with either of twostrains reduces tumor growth in MC38 colon carcinoma-bearing mice. Interestingly, only onestrain boosted the efficacy of cancer therapeutics, including oxaliplatin and PD-1 blockade. Extensive immune profiling and transcriptomic analysis revealed that the boostingstrain augments lymphocyte-mediated anti-cancer immunity. Our results suggest that supplementation withstrains could potentially be used as a strategy to enhance the efficacy of CRC therapeutics.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.